IL-6, soluble IL-6 receptor and IgG with anti-IL-6 activity were measured in the plasma of 14 lupus patients and 10 normal subjects. The capacity of peripheral blood mononuclear cells to spontaneously produce IL-6 in vitro was also measured. Our results indicate that IL-6 plasma levels in patient plasma as measured by ELISA were not different from normal but that supernatant levels were significantly lower than normal (P < 0.05). In vitro IgG production was comparable for all lupus patients' cells irrespective of the in vitro IL-6 levels. Plasma soluble IL-6 receptor levels directly correlated with IL-6 production capacity of SLE cells and the ratio of soluble receptor to anti-IL-6 directly correlated with IL-6 production in patients but not in normals. Inhibition assays demonstrated competition between anti-IL-6 and soluble receptors for IL-6 and the inhibition by plasma of IL-6 binding to monoclonal anti-IL-6. We believe the interaction of anti-IL-6 and IL-6 receptor with IL-6 may contribute to the homeostasis in IL-6 activity in vivo and skewing of the soluble receptor/anti-IL-6 ration may contribute to the lupus disease process.
Snick JVInterleukin-6: an overview. Ann Rev Immunol1990; 8: 253-78.
2.
Wong CG, Clark SCMultiple actions of interleukin-6 within a cytokine network. Immunol Today1988; 9: 137-9.
3.
Arend WP, Dayer JMCytokines and cytokine inhibitors or antagonists in rheumatoid arthritis . Arthritis Rheum1990; 33: 305-14.
4.
Manicourt DH , Triki R., Fukuda K., Devogelaer JP, Deuxchaisnes CN , ThonarEJMA. Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratin sulfate. Arthritis Rheum1993; 36: 490-9.
5.
Benedetti FD , Masa M., Robbioni P., Ravelli A., Burgio GR, Martini A.Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum1991; 34: 1158-63.
6.
Israeli ML, Deans RJ, Wallace DJ, Prehn J., Chen TO, Klinenberg JRElevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol1991; 147: 117-23.
7.
Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M.Synovium as a source of interleukin-6 in vitro; contribution to local and systemic manifestations of arthritis. J Clin Invest1989; 83: 585-92.
8.
Hirohata S., Miyamoto T.Elevated levels of IL-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum1990; 33: 644-9.
9.
Spronk PE, Borg Ejt, Limburg PC, Kallenberg Cgm.Plasma concentration of IL-6 in systemic lupus erythematosus; an inhibitor of disease activity?Clin Exp Immunol1992 ; 90: 106-10.
10.
Gabay C., Roux-Lombard P., Moerloose PD, Dayer JM, Vischer T., Guerne PAAbsence of correlation between interleukin-6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis . J Rheumatol1993; 20: 815-21.
11.
Martens E., Dillen C., Put W., Heremans H., Damme JV, Billiau A.Increased circulatory interleukin-6 activity in endotoxin-challenged mice pretreated with anti-IL-6 antibody is due to IL-6 in antigen-antibody complexes . Eur J Immunol1993; 23: 2026-9.
12.
Hansen MB, Svenson M., Diamant M., Bendtzen K.Anti-interleukin-6 antibodies in normal human serum. Scand J Immunol1991; 33: 777-81.
13.
Takemura H. , Suzuki H., Yushizaka K. et al. Anti-interleukin-6 autoantibodies in rheumatic diseases. Increased frequency in the sera of patients with systemic sclerosis. Arthritis Rheum1992 ; 35: 940-3.
14.
Heremans H. , Dillen C., Put W., Damme JV, Billiau A.Protective effect of anti-interleukin-6 antibody against endotoxin associated with paradoxically increased IL-6 levels. Eur J Immunol1992 ; 22: 2395-401.
15.
Mihara M., Koishihara Y., Fukui H., Yasukawa K., Ohsugi Y.Murine anti-human IL-6 monoclonal antibody prolongs the half-life in circulating blood and thus prolongs the activity of human IL-6 in mice . Immunology1991; 74: 55-9.
16.
Taga T., Hibi M., Hirata Y.Interleukin-6 triggers the association of its receptor with a possible signal transducer gp 130. Cell1989; 58: 573-81.
17.
Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271-7.
18.
Suenaga R., Evans M., Hatfield M., Abdou NIStudy of anti-DNA antibodies prepared by DNA cellulose or Cibacron blue chromatography . J Immunol Methods1986 ; 93: 131-40.
Hara Akm, Hirose T., Harigai M. et al. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol1992 ; 88: 75-83.
21.
Riquelme Mea , Moller G., Fernandez C.Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB X NZW) F 1 hybrid. Clin Immunol Immimopath1992 ; 62: 264-9.
22.
Pelton BK, Speckmaier M., Hylton W., Farrant J., Denman AMCytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus. Clin Exp Immunol1991; 83: 274-79.
23.
Klashman DJ , Martin RA, Maza OM, Stevens RHIn vitro regulation of B cell differentiation by interleukin-6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen-induced normal B cells. Arthritis Rheum1991; 34: 276-86.
24.
Lu ZY, Brochier J., Wijdenes J., Brailly H., Bataille R., Klein B.High amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Eur J Immunol1992; 22: 2819-24.
25.
Yawata H., Yasukawa K., Natsuka S. et al. Structure-function analysis of IL-6 receptor: dissociation of amino acid residue required for IL-6 binding and for IL-6 signal transduction through gp 130. EMBO J1993; 12: 1705-12.
26.
Novick D., Shulman LM, Chen L., Revel M.Enhancement of interleukin-6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody . Cytokine1992; 4: 6-11.
27.
Kobayashi I. , Matsuda T., Saito T. et al. Abnormal distribution of IL-6 receptor in aged MRL/LPR mice: elevated expression on B cells and absence on CD4+ cells . Int Immunol1992; 4: 1407-12.
28.
Finkelman FD , Madden KB, Morris SC et al. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol1993 ; 151: 1235-44.
